| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |